OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS LIFE MEMORANDUM TO THE APPOINTED ACTUARY

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS LIFE MEMORANDUM TO THE APPOINTED ACTUARY 2017

Table of Contents A. GENERAL REQUIREMENTS AND DIRECTIONS... 4 A.1 Overview... 4 A. 2 Regulatory Requirements... 5 A.2.1 Application of Professional Standards to the Appointed Actuary s Valuation... 5 A.2.2 Filing Directions of AAR, DCAT Report and Peer Review Report... 6 A.3 OSFI s Review Process... 6 A.4 Definition of Liabilities for Insurance Contracts, Investment Contracts, Other Contract Liabilities and Assets... 7 B. GENERAL LAYOUT... 9 B.1 OVERVIEW... 10 B.1.1 Overview of the Company... 10 B.1.2 Opinion... 10 B.1.3 Materiality Standards... 10 B.2 TOTAL CONSOLIDATED COMPANY DATA... 11 B.2.1 Summary Reporting of Consolidated Data... 11 B.2.2 Summary Reporting of Other Contract Liabilities... 14 B.2.3 Summary Reporting of Provisions for Adverse Deviations... 16 B.2.4 Summary Reporting of Changes in Methods and Assumptions... 18 B.3 DETAILS BY ASSET SEGMENTS AND PRODUCT LINES... 22 B.3.1 Asset Segment Reporting... 22 B.3.2 Product Line Reporting... 25 B.3.2.1 Product Data:... 25 B.3.2.2 Description of Product:... 26 B.3.2.3 New Products:... 26 B.3.2.4 Reinsurance:... 26 B.3.2.5 Expected Experience Assumptions:... 26 B.3.2.6 Economic Assumptions:... 27 B.3.2.7 Mortality/Morbidity Improvement:... 31 B.3.2.8 Margins for Adverse Deviation for Non-economic Assumptions:... 31 B.3.2.9 Method and Assumption Changes:... 32 B.3.2.10 Other:... 32 B.3.2.11 Bulk Liabilities:... 33 B.3.2.12 Type of Valuation Approach or System:... 33 B.3.2.13 Internal Control Analysis of Insurance Contract Liabilities:... 33 B.3.2.14 Comparison With Other Reporting:... 34 B.3.2.15 Interest Rate Guarantees:... 34 B.4 ADDITIONAL LIABILITY DISCLOSURES... 35 B.4.1 Credit Risk... 35 B.4.2 Expenses... 37 B.4.3 Deferred Taxes in Liabilities... 38 B.4.4 Index-Linked UL and Annuity Products... 38 OSFI Life Memorandum to the Appointed Actuary, 2017 Page 2 of 57

B.4.5 Segregated Fund Products: Liability and Capital Provision... 38 B.4.6 Deferred Acquisition Cost for Segregated Funds... 41 B.4.7 Guarantees... 41 B.4.8 Fraternal Funds... 41 B.4.9 Surplus... 42 B.4.10 Bulk Liabilities... 42 B.4.11 Reinsurance... 42 B.4.12 Currency Exchange Rates... 44 B.4.13 Inter-Segment Notes... 44 B.5 ASSET/LIABILITY MANAGEMENT (ALM)... 45 B.5.1 Overview of the Asset Liability Risk Management Practice... 45 B.5.2 Immunization... 45 B.5.3 Investment Guidelines... 46 B.5.4 Risk Metrics... 46 B.6 SOURCES OF EARNINGS... 48 B.7. REPORT ON PARTICIPATING POLICIES... 50 B.7.1 Participating Account and Sub-Account Disclosure... 50 B.7.2 Participating Closed Blocks... 51 B.7.2.1 Reporting... 51 B.7.2.2 Ongoing Opinions... 51 B.7.2.3 AAR Reporting... 52 B.8 OTHER DISCLOSURE REQUIREMENTS... 53 B.8.1 Dynamic Capital Adequacy Testing (DCAT)... 53 B.8.2 New Appointment... 53 B.8.3 Annual Required Reporting to the Board or Audit Committee... 53 B.8.4 Continuing Professional Development Requirements... 54 B.8.5 Disclosure of Compensation... 54 B.8.6 Reporting Relationships of the Appointed Actuary... 55 B.8.7 Peer Review of the Work of the Appointed Actuary... 55 Appendix I Opinion of the Appointed Actuary... 57 OSFI Life Memorandum to the Appointed Actuary, 2017 Page 3 of 57

A. GENERAL REQUIREMENTS AND DIRECTIONS A.1 Overview This Memorandum describes the requirements of the Office of the Superintendent of Financial Institutions (OSFI or Superintendent) with respect to the Appointed Actuary s Report (AAR) specified in subsection 667(2) of the Insurance Companies Act (ICA), sets out the minimum standards used in determining the acceptability of the AAR and provides guidance for the Appointed Actuary preparing reports in matters relating to presentation, level of detail and nature of the discussions to be included. Many insurers are required to file an AAR, as part of the Annual Return forms, with more than one regulator, federal or provincial, in Canada. It is the responsibility of the insurer to ensure that the AAR submitted as part of the Annual Return complies with the requirements of each regulator. The term AAR refers to the detailed actuarial report submitted to a regulator. This includes the opinion of the Appointed Actuary concerning the fairness and adequacy of the policy liabilities included in the insurer's financial statements, a detailed commentary, data exhibits and calculations supporting that opinion. The purpose of the AAR is to give OSFI a comprehensive report documenting the work done by the Appointed Actuary to calculate the policy liabilities. The AAR also documents the work the Appointed Actuary does for the administration of Participating Accounts. The AAR is a key component in OSFI s review process of the Company s financial position and profile. The AAR should not be considered to solely be a report from the company s Appointed Actuary to OSFI s actuaries. It is also intended for company management and is read by regulators who may not be actuaries but who are knowledgeable about insurance. It should be a generally understandable presentation that can be used as a key component in OSFI s monitoring of the company s financial results. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 4 of 57

A. 2 Regulatory Requirements A.2.1 Application of Professional Standards to the Appointed Actuary s Valuation Subsections 365(2) and 629(2) of the ICA require that: The actuary s valuation shall be in accordance with generally accepted actuarial practice with such changes as may be determined by the Superintendent and any additional directions that may be made by the Superintendent. OSFI s Guideline E-15 Appointed Actuary: Legal Requirements, Qualifications and Peer Review describes all of the duties of the Appointed Actuary and the qualifications that OSFI expects the Appointed Actuary to have. The Canadian Institute of Actuaries (CIA) annually issues a letter (the Fall Letter) from the Committee on Life Insurance Financial Reporting (CLIFR) and, from time to time, may issue other educational notes. While both the Fall Letter and educational notes are not standards, the Appointed Actuary should disclose when either the educational notes and/or the CLIFR Fall Letter are/is not followed as well as the supporting justification. For purposes of the Appointed Actuary s valuation of policy liabilities (and the associated opinion), OSFI currently accepts that work performed in accordance with accepted actuarial practice in Canada (as defined by the CIA) is sufficient to satisfy the generally accepted actuarial practice requirement referred to in the ICA sections identified above. Accepted actuarial practice is defined by the professional actuarial standards of practice promulgated by the Actuarial Standards Board (ASB), together with the additional requirements and directions of this Memorandum. Any deviations from CIA Standards of Practice or from the additional requirements of this Memorandum must be reported in the AAR and justified. This Memorandum for 2017 year-end financial reporting does not contain any requirements that override or limit accepted actuarial practice. In complying with accepted actuarial practice, the Appointed Actuary must meet a standard of care with respect to the data used in valuations. This standard of care, implicitly stated in the CIA Standards of Practice, requires the Appointed Actuary to establish suitable check procedures for the verification of data. While the CIA Standards of Practice (SOP Subsection 1630) offer the Appointed Actuary the option to consider the Auditor s work, the existence of the Joint Policy Statement does not override the ICA s requirement for filing reports with the Annual Return that meet the standard of care implicitly stated in the CIA Standards of Practice. The extent to which the Appointed Actuary considers the work of the Auditor must be discussed in the AAR. Where the Appointed Actuary uses the work of the Auditor, the details of the Auditor s work should not be addressed in the AAR. If there are instances where the Appointed Actuary does not use the work of the Auditor because of any special circumstances, this must be disclosed in the product sections of the AAR. In such cases, the Appointed Actuary should describe the data verification that was performed. The CIA Standards of Practice (SOP Subsection 1610) describe the Appointed Actuary s use of another person s work. Such use of the work of others should be disclosed in the section of the AAR where it most logically applies (e.g., at the company level, a specific product level, etc.). OSFI Life Memorandum to the Appointed Actuary, 2017 Page 5 of 57

A.2.2 Filing Directions of AAR, DCAT Report and Peer Review Report The deadline for filing the AAR is 60 days after the end of the fiscal year. The requirement for filing the DCAT Report is the earlier of 30 days after the presentation to the Board of Directors, Audit Committee or Chief Agent and one year after the fiscal year end. The requirement for filing the Peer Review Report (full 3-year review or the limited annual review) is 30 days after its transmission to the Board of Directors, Audit Committee or Chief Agent. With respect to deadlines, refer to OSFI s Guideline E-15 Appointed Actuary: Legal Requirements, Qualifications and Peer Review. For the AAR, the DCAT Report and the Peer Review Report, the company is required to submit one electronic copy uploaded via the Regulatory Reporting System (RRS). A scanned copy of the signed opinion must be included in the electronic submission. Failure to meet the deadlines for the filings might result in a penalty fee under OSFI s Late and Erroneous Filing Penalty Framework. For security reasons, e-mail should not be used. For the AARs, the DCATs and the Peer Review Reports the company is required to submit: One electronic copy uploaded to a secure web portal; Word or pdf format, with pdf preferred; One electronic copy of the required tables in the AAR in Excel format (life companies only); and Note: No hard copies are required, with the exception of some institutions for the AAR. The companies this applies to will be contacted individually. For the file naming conventions, follow the instructions for Unstructured Financial Returns. Both the full 3-year peer review and the limited annual peer review share the same naming conventions. Instructions on the use of the web portal can be found on OSFI Website at www.osfi-bsif.gc.ca under Regulatory Data and Returns / Filing Financial Returns / Canadian & Foreign Life Insurance Companies/Fraternals Benefit Societies. In order to file a Peer Review Report within RRS, insurers are reminded that these filings must first be requested by contacting ReturnsAdmin@osfi-bsif.gc.ca or by calling 613-991-0609. Insurers are reminded the filing of AARs and opinions with Annual Return forms requires that each copy of the Annual Return filed with OSFI should contain a properly signed copy of the AAR. An insurance company that files its Annual Return without including the AAR will not have satisfied the requirements of the ICA with respect to the filing of its Annual Return. A certificate containing only the opinion of the Appointed Actuary will not be accepted in lieu of a full AAR. A.3 OSFI s Review Process OSFI recognizes the confidential nature of the contents of the AAR. Reviews of the filed Annual Returns may disclose that an Appointed Actuary s valuation warrants further assessment and OSFI Life Memorandum to the Appointed Actuary, 2017 Page 6 of 57

questioning. The Superintendent may reject assumptions and methods where it appears that the policy liabilities produced are inappropriate. Since the review of an AAR may take place over an extended period after filing, OSFI may notify the Appointed Actuary that supplemental detail is required to sufficiently assess the assumptions and methods. The Appointed Actuary is expected to respond promptly to all supplemental requests. Working papers required to support the computation of the policy liabilities reported in the Annual Return and the AAR should be available at all times and should be made available to OSFI upon request. If the appropriateness of particular assumptions or methods is not sufficiently demonstrated, the Superintendent will require the Appointed Actuary to choose other acceptable assumptions or methods, and to re-compute the policy liabilities. In such a situation, the Appointed Actuary will have to re-file the AAR. The Superintendent may require the company to amend the Annual Return. Alternatively, the Superintendent may ask the company to reflect the changes in the Annual Return for the following year. The Superintendent may request an Independent Appointed Actuary s Report, if deemed necessary. A.4 Definition of Liabilities for Insurance Contracts, Investment Contracts, Other Contract Liabilities and Assets Subsections 365(1) and 629(1) of the ICA require the Appointed Actuary to value the liabilities for insurance contracts, investment contracts, reinsurance recoverables and other contract liabilities and assets of the company. These amounts are collectively referred to as policy liabilities and are covered by the Appointed Actuaries Opinion and are reported in the AAR. Specifically, this includes the following: Liabilities for insurance and investment contracts. The gross (net insurance contract liability plus reinsurance recoverables) amounts reported in the AAR must reconcile to the following amounts in the Annual Returns: Canadian Life Insurance Companies: LIFE Quarterly Return Page 20.020 Line 010 (Actuarial liabilities for insurance contracts) plus LIFE Annual Supplement Return Page 22.020 Line 450 (Actuarial liabilities for investment contracts) Canadian Fraternal Benefit Societies: LIFE Quarterly Return Page 20.021 Line 010 (Actuarial liabilities for insurance contracts) plus LIFE Annual Supplement Return Page 22.020 Line 450 (Actuarial liabilities for investment contracts) To support this reconciliation, the presence of the associated undiscounted deferred tax liability or asset, as determined by the accountants, should be clearly disclosed. CALM requires that the insurance contract liabilities include a discounted provision for deferred taxes. However, the Annual Return shows a separate undiscounted deferred tax asset or OSFI Life Memorandum to the Appointed Actuary, 2017 Page 7 of 57

liability (which is determined by the accountants), and an insurance contract liability reduced by the undiscounted deferred tax. Therefore, the total consolidated insurance contract liabilities appearing in the AAR must exclude the associated undiscounted deferred tax assets or liabilities. Practice varies by company regarding the level at which the undiscounted deferred tax is netted (e.g. by product line, business unit, company, etc.). The tables in the AAR should disclose at what level taxes are included. The AAR should clearly disclose whether or not the insurance contract liabilities for each product line include deferred taxes on a discounted or undiscounted basis and how these reconcile to the consolidated total that excludes the undiscounted deferred taxes. Also any disclosure of changes in insurance contract liabilities or provision for adverse deviations should clearly disclose whether or not these items include deferred taxes on a discounted or undiscounted basis. The same principles apply to the disclosure for the presence of any deferred tax assets or liabilities associated with investment contract liabilities. Other Contract Liabilities. The gross (net liability plus reinsurance recoverables) amounts reported in the AAR must reconcile to the following amounts in the Annual Return (less the liabilities held for investment contracts): Canadian Life Insurance Companies: LIFE Quarterly Return Page 20.020 Line 040 (Other Contract Liabilities) less LIFE Annual Supplement Return Page 22.020 Line 450 (Actuarial liabilities for investment contracts) Other Liabilities or Asset Provisions in the Annual Return that are inherently related to or linked to insurance contracts and investment contracts. Total Assets. The amounts reported in the AAR must reconcile to the following amounts in the Annual Returns: Canadian Life Insurance Companies: LIFE Quarterly Return Page 20.010 Line 899 OSFI Life Memorandum to the Appointed Actuary, 2017 Page 8 of 57

B. GENERAL LAYOUT The format and order of presentation specified in this Memorandum must be followed. The report is ordered so that summary total company information is presented first. This should give the reader an overview of the company s policy liabilities. The data should be ordered to be consistent with, first, the way that the company is reported externally and, second, the way that the company is managed, analyzed and reported internally. This requires that data be displayed in a descending cascade by company, country, asset segment and products. A uniform manner of presentation allows OSFI to more easily compare methodologies and assumptions between companies. The Appointed Actuary s Report is to have the following sections: Table of Contents 1. Overview 1.1. Overview of the Company 1.2. Opinion 1.3. Materiality Standards 2. Total Consolidated Company Data 3. Details by Asset Segment and Product Lines 4. Additional Liability Disclosures 5. Asset Liability Management (ALM) 6. Sources of Earnings 7. Report on Participating Policies 8. Other Disclosure Requirements The requirements for each of the above sections are detailed in this Memorandum. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 9 of 57

B.1 OVERVIEW B.1.1 Overview of the Company The overview section of the AAR should include: a brief description of the company s structure; an overview of its operations; any changes in structure; any acquisitions/divestitures; any key material events affecting the liabilities for insurance and investment contracts, and other contract liabilities; any changes in the philosophy towards the valuation of liabilities; and any material new categories of business. While the above should be disclosed in the overview section of the AAR, any extensive product specific details should also be disclosed in the appropriate product sub-sections. B.1.2 Opinion The Appointed Actuary must use the prescribed opinion format (see Appendix I). The opinion wording is as recommended in the CIA Standards of Practice Practice-Specific Standards for Insurers. Any different wording will be considered as a qualified opinion. This section must contain an original signature of the Appointed Actuary of the AAR, the Appointed Actuary s name in type, and the date of signing. The actuarial opinions presented to the shareholders and policyholders of an insurance company should be essentially the same as the opinions filed with OSFI. Should this not be the case, the Appointed Actuary is required to disclose in writing in the AAR to OSFI the material differences between the opinions, as well as the rationale for such differences. Any qualification or limitation concerning any aspect of the Valuation should be noted in this section of the AAR. These qualifications or limitations should be similar to the ones included in the opinion for Canadian Annual Returns presented to the shareholders and policyholders. B.1.3 Materiality Standards In preparing the company s Annual Return, the company management and the external auditor routinely agree on a level of materiality. The AAR must report these materiality standards. In addition, the Appointed Actuary must report on how the Annual Return materiality standard is selected in the valuation of policy liabilities. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 10 of 57

B.2 TOTAL CONSOLIDATED COMPANY DATA B.2.1 Summary Reporting of Consolidated Data Section B.2 of the AAR must show a set of seven tables, as follows: Table 2.1 - Consolidated Liabilities for Insurance and Investment Contracts Table 2.2a - Other Contract Liabilities Table 2.2b - Additional Contract Related Liabilities and Assets Table 2.3a - Provisions for Adverse Deviations, by Type Table 2.3b - Provisions for Adverse Deviations, by Year Table 2.4a - Liabilities for Insurance and Investment Contracts, Method and Assumption Changes, by Year Table 2.4b - Other Contract Liabilities, Method and Assumption Changes, by Year The following minimum levels of detail must be followed for the tables in Section B.2 of the AAR: Company: Data must be presented separately for each life insurance company that is consolidated in the Annual Return. This is required since the assets and liabilities are in separate legal entities. Country: If a company operates in more than one country, the data must be shown separately for each country, since in some cases there are local restrictions on the movement of assets and liabilities out of a country. Asset Segment: Each asset segment must be reported separately. The CIA Standards of Practice require that the valuation of the insurance contract liabilities has to be linked to the supporting assets. Typically, the assets backing one or more products reside in a single asset segment. The sample format for Table 2.1 is set up to capture this structure. However, there could be cases where a product line is backed by more than one asset segment, or some other combination of asset segments and product lines. In such cases, the Appointed Actuary has to decide how to modify the sample format so that the company s environment is clearly represented. Product Line Reporting: The definition of product line for the purposes of reporting in the AAR should be determined by the Appointed Actuary based on the circumstances of the company. Product lines should be reported separately in the AAR to the same extent that they are separately analyzed or reported to business unit management. Par and Non Par: Participating lines of business must be shown separately. Dollar Amount: The dollar amounts shown in the tables must be expressed in thousands. The above defines a cascade of levels of reporting that must be presented in the AAR. There is no requirement to do further breakdowns of data exclusively for AAR reporting, except where this is explicitly required in this Memorandum. This reporting structure and format must be followed by the company in order to more easily allow for comparisons between companies. The table must show how liability data is matched to the separate asset segments that constitute the company s asset structure. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 11 of 57

Only the level of detail, or order, shown in the three left columns of Table 2.1 should vary by company. The Appointed Actuary must determine the level of product detail to be shown that matches the above requirements. However, exceptions will be allowed depending on the particular circumstances of the company. If the company has a different structure (e.g., asset segments within product lines), such a structure should be used in the tables. Such deviations should be justified. The Appointed Actuary must use judgement in deciding on the level of detail reported in the AAR. The purpose of this summary table is to give the reader an overview of the company and its lines of business. The Appointed Actuary is discouraged from making this summary table too voluminous. However, if there are products grouped within an asset segment and not covered by the splits above, and which the Appointed Actuary considers to be significant, then their separation in this table is encouraged. The Appointed Actuary should be influenced by how the company s management looks at the business for internal reporting, while still respecting the required separation of companies and countries, as shown in section B.2.1 of this Memorandum. More detailed reporting is to be done at the asset segment and product line levels reported in later sections of the AAR. These requirements are covered in sections B.2.4 and B.3 of this Memorandum. Numbers reported at the total company summary level must reconcile to those reported in the detailed product sections. If a product line is shown separately in the summary tables, the same product line must be reported on separately in the detailed product sections. For the purposes of this report, Gross Liability is defined as Net Liability plus Reinsurance Recoverables. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 12 of 57

Summary Table 2.1 Consolidated Liabilities for Insurance and Investment Contracts ($, 000) Company/ Country Asset Segment Product Lines Liabilities 2017 Liabilities 2016 Liabilities 2015 Parent Co. - Canada Parent Co. - U.S. Parent Co Total Subsidiary Comp. #1 Consolidated Total Segment #1 Product #1 Product #2 Product #3 Segment Total Segment #2 Product #4 Product #5 Segment Total Segment #3 Segment Total Seg Funds Segment Total Surplus Misc. Liabs Canada Total Segment #4 Product #1 Product #2 Segment Total Segment #5 Product #3 Product #4 Segment Total Surplus Misc. Liabs U.S. Total Segment #6 Product #1 Surplus Total Subsid. # 1 Segment Total Misc. Liabs Gross Net % Gross Net % Gross Net % The percentages required in the above table are the ratios of each of the net contract liabilities to the consolidated total. This sample chart shows separate asset segments for surplus. However, each company can have its asset segments organized in a different way. Some companies may have surplus inside the other asset segments. Some companies may have corporate asset segments. The sample chart also shows liabilities inside a surplus segment. Again, this may be true for some companies and not for all. The company s actual structure should be used in determining the contents of the three left columns. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 13 of 57

Not all companies do income tax calculations at the product level. Allocations should not be done just for purposes of reporting in this table. Refer to Section A.4 of this memorandum for instructions on reconciliation to the Annual Return. B.2.2 Summary Reporting of Other Contract Liabilities The liabilities in Table 2.2a must be shown separately for each company, country and par/nonpar detail, corresponding to Table 2.1 above. These liabilities are not required to be reported in detail by product line. However, if there is a material amount which the Appointed Actuary judges to be significant, more details are expected to be provided in the Product Line Reporting (Section B.3.1). In particular, if the other category is significant, more detailed disclosure is required. The liabilities in Table 2.2a must not include liabilities for investment contracts. (Liabilities for investment contracts are to be included in Table 2.1) The table should show the other liabilities by type. The following sample table shows the format style that the company is expected to follow. Summary Table 2.2a Consolidated Other Contract Liabilities ($, 000) Company/Country Liability Type 2017 2016 2015 Parent Co. Canada Parent Co. U.S. Claims reported but not admitted Claims incurred but not reported Provision for exp. Rating refunds Dividends on deposit Proceeds on deposit Premiums paid in advance Premiums on deposit Other Subtotal Claims reported but not admitted Claims incurred but not reported Provision for exp. Rating refunds Dividends on deposit Proceeds on deposit Premiums paid in advance Premiums on deposit Other Subtotal Total OSFI Life Memorandum to the Appointed Actuary, 2017 Page 14 of 57

In addition to the liabilities in Table 2.2a, the Appointed Actuary must disclose any other liabilities in the Annual Return that are inherently related to insurance and investment contracts. Included in this are liabilities that were determined by the Appointed Actuary or where the size of the liabilities depends on the Appointed Actuary s judgement. The Appointed Actuary must disclose in which line of the Annual Return each of these liabilities reside. Similarly, the Appointed Actuary must disclose any assets whose amount depends on the Appointed Actuary s judgement. Examples of such assets include, but are not limited to, some reinsurance receivables, reverse mortgages (whose value depends on assumptions such as real estate appreciation, mortality, etc.), value of warranties on acquired blocks, etc. The Appointed Actuary must disclose in which line of the Annual Return each of these liabilities reside. The liabilities and assets in Table 2.2b must be shown separately for each company, country and par/nonpar detail, corresponding to the level of detail shown in Table 2.1 above. The following sample table shows the format style that the company is expected to follow for reporting such liabilities and assets. Summary Table 2.2b Consolidated Additional Contract Related Liabilities and Assets ($, 000) Company/Country Parent Co. Canada Parent Co. U.S. Liability or Asset and Annual Return Line Subtotal Subtotal Total 2017 2016 2015 OSFI Life Memorandum to the Appointed Actuary, 2017 Page 15 of 57

B.2.3 Summary Reporting of Provisions for Adverse Deviations Section 2.3 of the AAR must show two tables of the Provisions for Adverse Deviations (PfADs) that are included in the liabilities: 1) by type and 2) by year. The company/country/asset segment/product combinations must be the same as shown in Table 2.1 described above. All the provisions disclosed in the AAR must be on a before-tax basis. Table 2.3a below shows the provisions for the current year by type of provision. The table cannot be altered by combining columns or removing columns. The Appointed Actuary must ensure that this table is completed in the stated format. All the rows and columns in the table below are expected to be shown. Column headings should not be changed or reordered. If no data is available, columns should be left blank. Summary Table 2.3a Provisions for Adverse Deviations by Type ($, 000) (Net of Reinsurance Recoverables) Company/ Country Parent Co. - Canada Asset Segment Product Lines Seg. #1 Product #1 Product #2 Liab. Fixed Income Credit Loss Credit Spread Additional PfAD outlined in 2330.07.01 (*) Mort. Provisions for Adverse Deviations (PfAD) 2017 Mort. Improvement Morb. Morb. Improvement Expense Lapse Int. Rate C3 Equity/ Real Estate Additional PfAD for NFI usage (**) Other/ General (***) Total PfADs % of Liabs. ****Prescribed Mortality Improvement Seg. Total Seg. #2 Product #3 Product #4 Seg. Total S.F. Seg. Total Surplus Misc. Liabs Parent Co. U.S. Canada Total Seg. #4 Product #1 Product #2 Seg. Total Seg. #5 Product #3 Seg. Total Surplus Misc. Liabs U.S. Total Parent Co Total Subsidiary Comp. #1 Seg. #6 Product #1 Seg. Total Surplus Misc. Liabs Total Subsid. # 1 Consol. Total *Note: The disclosure should include additional PfADs resulting from net credit spread after margin exceeding the maximum for any assets within an asset subgroup, as outlined in paragraph 2330.07.01 of the SOP. **Note: The disclosure should include additional PfADs for non-fixed income assets (NFI) usage per section 2340.20 of the SOP. ***Note: The disclosure should include the reasons for holding the Other/General PfAD, the methods and the assumptions used to determine the Other/General PfAD. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 16 of 57

****Note: This amount is calculated as the difference between the statement value and the value of insurance contract liabilities calculated using prescribed mortality improvement rates as promulgated by the Actuarial Standards Board (CIA Standards of Practice 2350.06). This amount is required by OSFI, for information only, to establish the amount of conservatism built into the statement value liability. Note that the net PfADs by type for the credit spread and the interest rate (C-3 risk) in the above table must not include the corresponding additional net PfADs. These additional net PfADs must be presented in the columns additional net PfADs. If not, the actuary must provide explanations below the previous table. If the valuation methodology used does not produce separate PfADs for each of the product lines in the table (e.g., if the Canadian Asset Liability Method (CALM) method aggregates some products), the disclosure in the above table should be at the level at which it is available. Allocations are not required just for purposes of reporting in this table. The Appointed Actuary must disclose whether the best estimate assumptions for life mortality or health morbidity include an assumption of improving mortality or morbidity. It is recognized that Appointed Actuaries calculate the amounts of the PfADs using different methodologies. The following are some examples of differences, each requiring disclosure: The amount value of each of the PfADs is calculated one at a time, while keeping the others unchanged. This will result in a balancing other component. The PfADs are calculated in a cumulative manner. The order of calculation can vary, and the resulting size of the individual PfADs can be different as a result. The calculations can include or exclude related deferred tax liability or asset on a discounted or undiscounted basis (and this should be clearly disclosed as per section A.4 of this memorandum). All such methods are acceptable for purposes of reporting in the AAR. OSFI expects there to be comparability in the calculation method by year. The Appointed Actuary should disclose the order in which the PfADs were calculated. If this varies by product line, this should be noted in the summary section of the AAR, and the details of the calculation method should be disclosed in the detailed product sections of this report. If the order of calculation has changed from the prior year for any product line, the rationale of the change should be noted in the summary section of this report. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 17 of 57

Table 2.3b below shows the provisions for adverse deviations included in the liabilities for the last three years. Summary Table 2.3b Provisions for Adverse Deviations by Year ($, 000) (Net of Reinsurance Recoverables) Company/ Country Asset Seg. Product 2017 2016 2015 Parent Co. - Canada Seg. #1 Product #1 Product #2 Product #3 Seg. Total Seg. #2 Product #4 Product #5 Seg. Total Seg. #3 Seg. Total S.F. Seg. Total Surplus Misc. Liabs Canada Total Parent Co. - U.S. Seg. #4 Product #1 Liabs. Amount of PfAD % of Liabs. Liabs. Amount of PfAD % of Liabs. Liabs. Amount of PfAD % of Liabs. Parent Co Total Subsidiary Comp. #1 Total Subsid. #1 Product #2 Seg. Total Seg. #5 Product #3 Product #4 Seg. Total Surplus Misc. Liabs U.S. Total Seg. #6 Product #1 Surplus Seg. Total Misc. Liabs Consol. Total If the valuation methodology used does not produce separate PfADs for each of the product lines in the table (e.g., if the CALM method aggregates some products), the disclosure in the above table should be at the level at which it is available. Allocations are not required just for purposes of reporting in this table. B.2.4 Summary Reporting of Changes in Methods and Assumptions The Appointed Actuary should confirm that the total changes (Gross and Net basis) at a Company level are reconciled to the numbers reported in the Quarterly and Annual Life Returns. Changes OSFI Life Memorandum to the Appointed Actuary, 2017 Page 18 of 57

in Methods and Assumptions should also be reconciled to basis changes in the Life Returns. Normal changes should be the difference between total and basis changes. The Appointed Actuary is required to explain any material differences between the basis changes reported in the Life Returns and the AAR as well as the rationale for such differences. Changes in Methods and Assumptions in the AAR table(s) should align with basis changes in the Life Return. Table 2.4a shows the methods and assumptions changes in liabilities for insurance and investment contracts. The company/country/asset segment/product line combinations must be the same as in Table 2.1 described above. The following is a sample of the table showing the changes in methods and assumptions for the last three years. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 19 of 57

Summary Table 2.4a Liabilities for Insurance and Investment contracts Method and Assumption Changes by Year ($, 000) (Net of Reinsurance Recoverables) Company/ Country Asset Segment Product Lines Parent Co. - Canada Seg. #1 Product #1 Product #2 Seg. Total Seg. #2 Product #3 Seg. #3 S.F. Surplus Product #4 Seg. Total Seg. Total Segment Total Misc. Liabs Canada Total Parent Co. - U.S. Seg. #4 Product #1 Parent Co Total Subsidiary Comp. #1 Total Subsid. # 1 Seg. Total Seg. #5 Product #3 Surplus U.S. Total Product #4 Seg. Total Misc. Liabs Seg. #6 Product #1 Surplus Seg. Total Misc. Liabs Impact on Liabs. 2017 2016 2015 Description of Change Impact on Liabs. Description of Change Impact on Liabs. Description of Change Consolidated Total A method or assumption change is defined as one that affects the liabilities of contracts that were inforce in the prior financial reporting period. The description of the changes shown in the table must be brief and succinct. Details describing the changes must be shown in the detailed product sections in Section B.3 of the AAR. Each of the changes in methods or assumptions must be disclosed separately. If more than one change is made to any of the products shown, the effects of each change must be shown separately and not netted. As indicated in section A.4 of this memorandum, the Appointed Actuary must disclose whether the impact on the liabilities includes or excludes the impact on the associated deferred tax assets or liabilities on a discounted or undiscounted basis. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 20 of 57

The effect of each change is required to be separately split into the following: those resulting from changes to expected experience; changes to Margins for Adverse Deviations (MfADs); changes resulting from special, particular or one-time circumstances (e.g., new standards, change in methodology, etc.); corrections to errors; changes due to a large non-usual transaction (e.g., reinsurance, acquisition, etc.); changes in bulk liabilities; changes due to any administrative and corporate changes (e.g., new systems, change in investment policy, etc.); and changes in Conditional Tail Expectation (CTE) levels when a stochastic model is used for valuation. When reporting to OSFI, quarterly changes in yield curve should not be considered as a basis change. It should be treated as a normal change in insurance contract liabilities. The Appointed Actuary must disclose in which quarter each change was made. Table 2.4b shows the method and assumption changes in other contract liabilities. The following is a sample of the table showing such changes in methods and assumptions for the last three years. Summary Table 2.4.b Other Contract Liabilities Method and Assumption Changes by Year ($, 000) Company/ Country Liability Type Impact on Liabilities 2017 2016 2015 Description of Change Impact on Liabilities Description of Change Impact on Liabilities Description of Change OSFI Life Memorandum to the Appointed Actuary, 2017 Page 21 of 57

B.3 DETAILS BY ASSET SEGMENTS AND PRODUCT LINES Section B.3 of the AAR is expected to document the asset segment and product line details of the valuation of the policy liabilities. This section of the AAR must follow the same order, and show the same combination of asset segments and product lines, as is shown in Summary Table 2.1. Thus, this section must follow the same cascade of company/country/asset segment/product. The amounts disclosed in this section (each asset segment and the related products) must correspond to those shown in Summary Table 2.1. The CIA Standards of Practice require that the valuation of the insurance contract liabilities be linked to the supporting assets. Typically, the assets backing one or more products reside in a single asset segment. The sample format for Table 3.1 is set up this way. However, there could be cases where a product line is backed by more than one asset segment, or some other combination of asset segments and product lines. In such cases, the Appointed Actuary should modify the sample format so that the company s environment is clearly represented while still being consistent with the spirit of the sample table. The table must show how liability data is matched to the separate asset segments that constitute the company s asset structure. It is recognized that not all of the elements that are requested to be disclosed are calculated at the same level of detail. Some examples of this are: The undiscounted deferred income taxes (as discussed in section A.4 of this memorandum) may be calculated at a higher level than the product line level of detail required by Table 3.1. The actual to expected studies may be at a summarized product level. Similarly, some of the descriptions of methodology or some assumptions may be the same for more than one product or asset segment. This need only be disclosed once in the AAR at the appropriate summary level, but the detailed product sections must make direct reference to it. Some examples of this are: Asset/Liability management (ALM) is the same; and The same mortality table is used for several product lines. It is required that each product section be self-contained. It must either have the data within the section, or there must be an explicit reference to a specific page at a different summarized level. The reader of the AAR should not have to search through non-cross-referenced sections of the AAR. B.3.1 Asset Segment Reporting The composition of each asset segment must be documented separately in the AAR in a table with the following format. The major asset and liability categories must be shown for the last three years. The liabilities for insurance and investment contracts, and other contract liabilities, supported by the asset segment must be included in the table. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 22 of 57

Table 3.1 Asset Segment Assets and Liabilities ($, 000) (Statement Carrying Values at December 31) Company/Country/Asset Segment 2017 Statement Asset Value Bonds: Held for Trading or FVO Available For Sale Other Mortgages: Held for Trading or FVO Available For Sale Equities: Other Held for Trading or FVO Available For Sale Other Real Estate Policy Loans Cash and S.T. Inter-Seg. Notes Inter-Company Derivatives Other Investments Other Investment #1 Other Investment #2 Deferred Tax Assets Reinsurance Recoverables* Other Assets Total * Reinsurance recoverables is referred to as reinsurance assets in LIFE-1. Liabilities for insurance and investment contracts Product #1 Product #2 Etc. Net Deferred Gains/Losses on R.E. Inter-Company Deferred Tax Liability. Other Liabilities Total Liabilities Surplus 2017 Gross Ceded Net All the rows in the tables above are expected to be shown. Do not blank out rows that do not apply, but explicitly show them to be zero. Three years of data are required. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 23 of 57

The Appointed Actuary should disclose the policy for determining the type of assets (held to maturity, available for sale, trading, fair value option) used to back the liabilities in this asset segment. The Statement asset values should be the same as are used in the Annual Return. The total of all Statement asset values for all the segments reported must equal the total assets (after inter-segment notes and inter-company loans are eliminated) on the balance sheet in the Annual Return (see Section A.4). The inter-segment notes should be shown as positive and negative amounts in the chart above. If there are any other assets, other liabilities, or other investments which are material to that asset segment, the Appointed Actuary is expected to provide more detail. The net investment income must include the amortization of the real estate net deferred gains/losses. The investment income must be the same definition as used in the Annual Return. It would include net realized gains on assets designated Available for Sale and changes in fair value for assets designated Held for Trading or Fair Value Option. Note that net investment income on the Annual Return also includes any net incurred credit losses. For assets designated Available for Sale or loans, there would be explicit write downs or provisions set up, but for assets designated Held for Trading or Fair Value Option, net incurred credit losses would be implicit in the Change in Fair Value portion of net investment income. If the asset mix, including bond quality, has changed materially between years, the reason for this should be discussed. If the investment policy has changed, the effect on the policy liabilities should be discussed. The use of assets other than bonds, mortgages, equities, real estate, policy loans and cash to back insurance contract liabilities must be disclosed. Such assets include, but are not limited to, intersegment notes, deferred tax assets, derivatives, goodwill, loans to subs or parents, etc. As required by ICA subsection 611.1(1), only vested assets may be used by foreign companies to determine their contract liabilities. The Appointed Actuary should disclose the company s policy with respect to the level of assets in each segment, transfers in and out of segments, frequency of transfers, new inter-segment or inter-company notes and policies with respect to surplus held within asset segments that back liabilities. For interest sensitive asset segments, the AAR must have a discussion of the asset liability management applied. The requirements for this reporting are shown in Section B.5 of this Memorandum. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 24 of 57

B.3.2 Product Line Reporting Within each asset segment, the Appointed Actuary must separately discuss the valuation of the products that have been shown in Table 3.1. The reporting of each product should include the following: B.3.2.1 Product Data: Table 3.2.X (X = Product Name) Product Data ($, 000) (At December 31) Company & Country Asset Segment Product #1 Liabilities for Insurance contracts and Investment contracts: Face Amount: Account Values: Premiums: Gross Net Gross Net Gross Net First Year Single Renewal Less, Ceded PfAD (on a before-tax basis) as a % of Net Liabilities: Fixed Income Credit Loss Credit Spread Additional PfAD outlined in 2330.07.01 Mortality Mortality Improvement Morbidity Morbidity Improvement Expenses Lapses Interest Rate C3 Equity/ Real Estate Additional PfAD for NFI Usage Other/ General Total PfAD Change in Liabilities From Method and Assumption Changes: Expected Liabilities MfADs 2017 2016 2015 OSFI Life Memorandum to the Appointed Actuary, 2017 Page 25 of 57

The above data must be shown for each of the products. The amount of liabilities must reconcile to the amounts shown in Summary Table 2.1. The Appointed Actuary must disclose whether the liabilities and PfADs include or exclude related deferred tax assets or liabilities on a discounted or undiscounted basis as required by section A.4 of this memorandum. The purpose of showing face amounts, account values and premiums is to give an overview of the size of the product, which may not always be understood just from the size of the liabilities. Face amount should be shown for life insurance products. Account values should be shown for universal life, segregated fund and deferred annuity contracts. The AAR should note the basis for the premiums shown (e.g., on the same basis as shown in the income statement of the Annual Return, annualized basis from valuation system, etc.). B.3.2.2 Description of Product: A description of the product and its key features must be disclosed. This should disclose details on the features of the product, the guarantees, benefits, contract durations, etc. The level of detail in this description should be sufficient to justify the methodology and assumptions used. Please indicate for each product whether they are open, closed, or closed but open for new deposits. The Appointed Actuary should discuss the key risks in each of the products. For instance, the Appointed Actuary should disclose the assumptions for which a misestimation would have the largest effect on the policy liabilities, which assumptions are the most volatile, and the results of any testing done for sensitivity analysis. B.3.2.3 New Products: The AAR should disclose details on the features of the new products, the guarantees, benefits, contract durations, etc. This description should be sufficient to justify the assumptions and methodology used. Where the product is novel or experimental, and relevant experience data is not available, the Appointed Actuary should describe the work performed to measure the risk associated with these new contingencies. B.3.2.4 Reinsurance: Where reinsurance is material, a description of the reinsurance structure with respect to risks and allowances should be included. Any new reinsurance treaty or other arrangement, assumed or ceded, must be disclosed. Disclosure should include the effective and expected termination dates, the type of reinsurance, a description of the products covered, recapture provisions, and any significant impact to liabilities for insurance and investment contracts and capital. B.3.2.5 Expected Experience Assumptions: The Appointed Actuary must document all expected experience assumptions used in the valuation, describing their rationale, justification and validation. This includes mortality, morbidity, interest, credit loss, lapses, expenses, inflation, renewal/conversion, disability/recovery, income taxes and any other contingencies that are applicable. OSFI Life Memorandum to the Appointed Actuary, 2017 Page 26 of 57

While all assumptions are expected to be documented, the Appointed Actuary must use judgement in deciding on the amount of detail included in the AAR with respect to assumptions. For instance, multi-page listings of mortality/morbidity tables or lapse tables are discouraged. The AAR must disclose how the expected experience assumptions were determined with specific reference to company experience studies and industry data as applicable. The credibility of the company data is to be disclosed, as is any blending of company and industry data. The Appointed Actuary should describe the source of the expected experience assumptions. If industry experience is used, this should be stated. If industry tables are available, but not used, the Appointed Actuary should show how the assumptions compare with the industry tables. For assumptions where limited experience exists, the Appointed Actuary should disclose the basis and rationale for determining the assumptions. Any use of implicit assumptions or approximations requires disclosure and discussion. For participating and adjustable products, the Appointed Actuary should describe how the dividends and non-guaranteed elements are reflected in the calculation of the insurance contract liabilities. The Appointed Actuary should disclose when the expected experience assumptions were last updated or reviewed, and briefly describe the policy(ies) and guidelines that govern how frequently each material expected experience assumption is to be updated or reviewed. If the frequency of updating or review of expected experience assumptions is not governed by any policy or guideline, this should also be noted. A comparison of actual experience versus expected experience assumptions should be shown separately for each material assumption within each product and for the last three years if the data is available. Where such studies are done at a more aggregate level than the product level, this information should be shown. This comparison should be shown separately for the key risk assumptions. The results for lapse should be shown separately for lapse-supported products and nonlapse supported products. This analysis does not require a full formal experience study. It could consist of expected experience per the valuation system versus actual experience taken from the accounting data. Consistent differences in one direction and large swings should be explained. If such actual to expected comparisons are done for only a portion of the product lines, the AAR should show the proportion that is measured. If such studies are not available, this should be disclosed. B.3.2.6 Economic Assumptions: The AAR must report the key future reinvestment rates and reinvestment strategies assumed and how the valuation models reflect the investment practices. The Appointed Actuary should disclose how ALM or investment policies and limits are reflected under the constraint that the insurer s expected investment practice should be determined without taking into consideration any business that could be issued after the valuation date (Paragraph 2330.05 of the SOP). OSFI Life Memorandum to the Appointed Actuary, 2017 Page 27 of 57